Cargando…
Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption
In December 2019, the 2019 novel coronavirus disease (COVID-19), which has been identified to be caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China and spread across the world. Higher plasma levels of cytokines, including interleukin (IL)-6, IL-2, IL-7, IL-10, a...
Autores principales: | Du, Yinke, Qi, Zhipeng, Ma, Jiangwei, Sun, Da, Yao, Li, Xu, Bin, Liu, Wei, Xu, Zhaofa, Deng, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736073/ https://www.ncbi.nlm.nih.gov/pubmed/33335906 http://dx.doi.org/10.3389/fmed.2020.607849 |
Ejemplares similares
-
Case report: Cytokine hemoadsorption in a case of hemophagocytic lymphohistiocytosis secondary to extranodal NK/T-cell lymphoma
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2022) -
Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2022) -
Hemoadsorption in LVAD Surgery: Suitable in Theory?
por: Ozturk, Mahmut, et al.
Publicado: (2023) -
Research progress on the role of type I vesicular glutamate transporter (VGLUT1) in nervous system diseases
por: Du, Xianchao, et al.
Publicado: (2020) -
Cytokine Hemoadsorption in the Management of a Pregnant Woman with COVID-19 Pneumonia: Case Report
por: Karabulut Keklik, Esra Sultan, et al.
Publicado: (2020)